Page 2 - Nasdaq Pdsb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq pdsb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pdsb Today - Breaking & Trending Today

PDS Biotechnology (PDSB) Set to Announce Quarterly Earnings on Monday

PDS Biotechnology (NASDAQ:PDSB – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, August 14th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter. PDS Biotechnology (NASDAQ:PDSB – Get Free Report) last posted its earnings results on Monday, May 15th. The company reported […] ....

Morgan Stanley , Biotechnology Corporation , Renaissance Technologies , Millennium Management , Get Free Report , Two Sigma Investments , Sigma Investments , Pds Biotechnology , Nasdaq Pdsb ,

Short Interest in PDS Biotechnology Co. (NASDAQ:PDSB) Rises By 27.0%

PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 2,680,000 shares, a growth of 27.0% from the May 15th total of 2,110,000 shares. Based on an average trading volume of 693,800 shares, the days-to-cover ratio is […] ....

Capital Management , Connor Clark Lunn Investment Management Ltd , Ep Wealth Advisors , Knightsbridge Asset Management , Biotechnology Corporation , Clarity Wealth Management Inc , Pds Biotechnology Co , Get Rating , Asset Management , Lunn Investment Management , Clarity Wealth Management , Pds Biotechnology , Nasdaq Pdsb ,

PDS Biotechnology Post-ASCO Conference Call Tomorrow, June

FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a. ....

United States , Dave Schemelia , Deanne Randolph , American Society For Clinical Oncology , Biotechnology Corporation Nasdaq , Clinical Oncology , Call Information , Nasdaq Pdsb , Pds Biotechnology Corporation , Conference Call , Pds Biotechnology ,

Comparing Silverback Therapeutics (NASDAQ:SBTX) & PDS Biotechnology (NASDAQ:PDSB)

PDS Biotechnology (NASDAQ:PDSB – Get Rating) and Silverback Therapeutics (NASDAQ:SBTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Profitability This table compares PDS Biotechnology and Silverback Therapeutics’ […] ....

United States , Frankk Bedu , Biotechnology Corp , Silverback Therapeutics Inc , Get Rating , Silverback Therapeutics , Silverback Therapeutic , Pds Biotechnology , Nasdaq Pdsb , Stock Comparison , Stock Analysis ,

PDS Biotechnology (NASDAQ:PDSB) Shares Down 3.9%

PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating)’s stock price was down 3.9% on Monday . The stock traded as low as $6.13 and last traded at $6.33. Approximately 281,786 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 482,226 shares. The stock had previously closed at $6.59. Wall […] ....

Biotechnology Co , Oppenheimer Co , Blackrock Inc , Renaissance Technologies , Biotechnology Corp , Pds Biotechnology Co , Vanguard Group Inc , Dimensional Fund Advisors , Get Rating , Fund Advisors , Pds Biotechnology , Nasdaq Pdsb ,